Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (SNOW)

NCT03575598 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03575598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03575598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (SNOW)
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
August 30, 2018
Completion date
February 18, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma mouth, squamous cell carcinoma of the oral cavity, squamous cell carcinoma, head and neck